Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stanbio Expands International Distribution

By Labmedica staff writers
Posted on 14 Mar 2002
In a move to expand the distribution of its products, Stanbio Laboratory (Boerne, TX, USA) has agreed for BDS International Diagnostics Gmbh (Schwetzingen, Germany) to serve as the export sales office of Stanbio in Eastern and Western Europe, the Middle East, and the Indian subcontinent. More...
BDS' services will include supporting and managing existing distributors and selecting and training additional distributors.

Stanbio has been producing and marketing clinical diagnostic reagents and test kits since 1960. The company's in vitro diagnostic products include clinical chemistry, serology, pregnancy, urinalysis, occult blood, microbiology, hematology, blood-grouping products, and clinical instruments. Stanbio now supplies liquid-stable and dry-powder clinical reagents as well as innovative dry-chemistry systems.

"Our product offerings will be highly attractive to the European markets, and in BDS we have a partner who shares our philosophy of quality and service,” said William R. Pippin, president of Stanbio.




Related Links:
Stanbio
BDS

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.